Setting new standards in information exchange for the pharmaceutical and biotech industry
Since 2012, the Government Pricing industry primarily focused its energy on Medicaid as they awaited the AMP Final Rule. The changes with the 340B program and shift in payer mix to MMCOs caused operational challenges, increased financial, compliance and contractual burdens. With the increase in complexity of government pricing, the Conference Forum is expanding its coverage of the MRS Summit and is happy to announce that the 2015 program is newly branded as the Government Drug Pricing Forum.
The GDP Forum will cover changes in MDRP, 340B, Tricare and Medicaid Managed Care. It specifically addresses the AMP Final Rule, HRSA guidance and price reporting, rise of contract pharmacies, new state reporting requirements and government and commercial contracting rules. This event brings together CMS, FDA, IRS, HRSA, States and OIG to address how to be compliant with separate agency requirements. Attendees will walk away with a thorough overview of healthcare trends and GDP policies that drive strategic decisions and operational plans.
EVP, Policy and Research, PhRMA
Managing Director, Reimbursement and Health Policy, BIO
SVP and General Counsel, National Association Chain Drug Store (NACDS)
Assistant Inspector General for Evaluations, Office of Evaluation and Inspections, Office of Inspector General
VP, 340B Solutions, McKesson
Alice Valder Curran
Partner, Hogan Lovells
Partner, FDA & Life Sciences Practice Group, King & Spaulding
Key Manufacturer Voices
Government Contracts Compliance, Pfizer
Senior Account Manager, 340B Managed Care and Customer Operations, Genentech
Senior Director, Managed Markets and HCP Compliance, Iroko Pharmaceuticals
Senior Director, Payer Marketing and Contract Strategy, Daiichi Sankyo
Senior Director, Government Pricing and Commercial Operations, Dendreon
Director, Government Contracting and Pricing Compliance Officer, Johnson & Johnson
The GDP Forum Agenda Organized By:
- Healthcare Trends and Policy Expectations: From ACOs and AMP to Contract Pharmacies
- New State Reporting Requirements and Tricare Contracting
- Drug Channel Contracting Strategies
- Compliant Government Pricing Programs
Half Day Workshop Choices
- Government Pricing Programs 101
- 340B Program Policies, Operational Answers, and Audits Findings
Let us know if you have any questions and take advantage of the early bird rate.
We look forward to greeting you on February 11 in Washington DC.